Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anling Biomed
Shenzhen, Guangdong, Chinaanlingbio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Anling Biomed is a preclinical contract research organization (CRO) and a subsidiary of ZSHK Laboratories Limited. It provides GLP-compliant safety evaluation, pharmacokinetics (PK), and pharmacodynamics (PD) services for pharmaceutical and medical device developers. The company operates facilities in Shenzhen, Suzhou, and Hong Kong, supporting global regulatory submissions (NMPA, FDA, EMA).
- Therapeutic areas
- OncologyCardiovascularPulmonologyMetabolic Disorders
- Modalities
- Small moleculeBiologicMonoclonal antibodyCell therapyGene therapyCAR-T cell therapyCAR-NK cell therapyPeptidesChinese medicine
- Industry
- Contract Research Organization
02
Partnerships
Shanghai Institute of Materia MedicaChinese Academy of Sciences
Beyond the preview
Go deeper on Anling Biomed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anling Biomed.